RxDoctor Payments DataLook up a doctor →

Scariya Kumaramangalam, MD

Psychiatry · Huntsville, ALNPI 1417996372

Payments from drug & device makers

$440,222in general payments, 2019–2025

Across 1,244 payments — averaging $353.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$209K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$118K
  • Axsome Therapeutics, Inc.$72K
  • Vanda Pharmaceuticals Inc.$27K
  • Alkermes, Inc.$3K
  • Otsuka America Pharmaceutical, Inc.$2K
  • plus $9K from 29 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$440,222 in reported general payments places this provider in the 95th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$272,506
Medicare patients
239
Services billed
2,968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →